[Folic acid sensitive, non-megalocytic erythroblastopenia in an epileptic].
D000328:Adult; D000741:Anemia, Aplastic / Q000188:drug therapy / Q000209:etiology*; D000927:Anticonvulsants / Q000009:adverse effects*; D001772:Blood Cell Count; D001811:Blood Volume Determination; D001856:Bone Marrow Examination; D004487:Edema / Q000139:chemically induced; D004802:Eosinophilia / Q000139:chemically induced; D004827:Epilepsy / Q000097:blood / Q000150:complications*; D005076:Exanthema / Q000139:chemically induced; D005260:Female; D005492:Folic Acid / Q000627:therapeutic use; D006452:Hemoglobinometry; D006801:Humans; D006827:Hydantoins / Q000009:adverse effects*; D008607:Intellectual Disability / Q000209:etiology; D007970:Leukopenia / Q000139:chemically induced; D011693:Purpura / Q000139:chemically induced
D000927:Anticonvulsants; D006827:Hydantoins; D005492:Folic Acid
Erythroblastopénie non mégalocytaire et sensible à l'acidé folique chez une épileptique.